RxISK’s last story featured a young woman who went on Paxil soon after the Keller et al version of Study 329 was published. We would love to hear more from anyone who was put on an SSRI during this period or who was recruited into an SSRI trial. What were you told about the risks and what happened to you?
Study 329 has just gone live. The Restoring Study 329 article with its appendices, data, history, accompanying feature by Peter Doshi and editorial by David Henry can be found on the Restoring Study 329 site Study329.org.
Here are the key findings at present.